Skip to main content
Open Access Publications from the University of California

Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study

  • Author(s): Feng, Sandy
  • Klintmalm, GB
  • Lake, JR
  • Vargas, HE
  • Wekerle, T
  • Agnes, S
  • Brown, KA
  • Nashan, B
  • Rostaing, L
  • Meadows-Shropshire, S
  • et al.

Published Web Location
No data is associated with this publication.

This exploratory phase II study evaluated the safety and efficacy of belatacept in de novo adult liver transplant recipients. Patients were randomized (N=260) to one of the following immunosuppressive regimens: (i) basiliximab+belatacept high dose [HD]+myc

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item